Could tariffs in the USA lead to a shortage of Pharmaceuticals? The Industry warns that low-profit generic drugs are facing a production crisis.

The USA plans to impose additional tariffs on Pharmaceuticals, raising alarms in the generic drug Industry. Generic drugs account for 90% of the medication market in the USA, with thin profits and fierce competition; if tariffs are imposed, it could result in direct losses, leading some pharmaceutical companies to cease production and exit the market. Last year, the first quarter saw a record high in drug shortages in the USA, and the implementation of tariffs may exacerbate the supply crisis. India, as a major Global exporter of generic drugs, is likely to be hit hardest.

wallstreetcnApr 21 19:01

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

BenzingaApr 18 00:00 · Ratings

PetMed Express Analyst Ratings

BenzingaApr 18 00:00 · Ratings

Express News | Petmed Express Inc : Morgan Stanley Cuts Target Price to $3.20 From $3.50

BreakingsApr 17 18:28

Even With Tariffs Looming, Jim Cramer Says Consumer Companies Must Cut Prices

CNBCApr 17 07:16

PetMeds to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

GlobeNewswireApr 11 21:00